anal cancer

Zynyz

Pharma

Incyte secures anal cancer nods years after FDA rejection

Incyte's Zynyz has become the first treatment specifically approved by the FDA in first-line anal cancer.

Angus Liu May 16, 2025 10:10am

Incyte CEO Herv Hoppenot

Incyte CEO views PD-1 drug Zynyz as oncology pipeline aide

Sep 14, 2024 10:30am

question unanswered wonder ask

Incyte touts 2 trial wins for PD-1 drug Zynyz amid I-O retreat

Jul 30, 2024 11:27am

St. Jude's campaign educates about on-time HPV vaccine

Oct 13, 2022 8:50am